How to start the weight loss process with peptides or Ozempic/Wegovy/Mounjaro/Reta/Cargi drugs ?

1. Perform laboratory tests

WOMEN:

For menstruating women, tests should be performed between the 3rd and 5th day of the cycle, for non-menstruating women on any day.

• Morphology,
• OGTT 0-60-120 min for glucose with insulin (requires referral) / blood glucose and insulin test can be done interchangeably
• HbA1c
• Ferritin/B12/folic acid
• Lipidogram
• Uric acid
• ALT/AST/GGTP
• TSH/FT3/FT4/ATPO and ATG
• AMH
• Estradiol
• FSH
• LH
• Prolactin
• Androstenedion
• Creatinine
• eGFR
• D-dimers

MEN:

• Free testosterone
• Total testosterone
• Estradiol
• FSH/LH/ALT/AST/GGTP
• OGTT 0-60-120 min for glucose with insulin (requires referral) / blood glucose and insulin test can be done interchangeably
• HbA1c
• Uric acid
• B12/ferritin/folic acid
• Morphology
• TSH/FT3/FT4/ATPO and ATG
• Prolactin
• Lipidogram
• Creatinine
• eGFR
• D-dimers

You must not have any abnormalities in the above tests, especially in the pancreas, liver and sugar metabolism.

2. Determination of the type of obesity – overweight

Obesity is a complex health problem that can be classified in various ways. One popular classification method is the use of body mass index (BMI), but there are other categories and classification methods that take into account other factors, such as fat distribution, body circumference, waist-to-hip ratio, etc. Below I present the classification of obesity in women and men, taking into account both BMI and other factors:

Classification of obesity by BMI:

1. ** Type I obesity:**.

• **BMI:** 30.0-34.9 kg/m² (class I).
• **Diagnosis:** The presence of excessive body fat, confirmed by measuring the body mass index.

2. ** Type II obesity:**.

• **BMI:** 35.0-39.9 kg/m² (class II).
• **Diagnosis:** Significant health risks associated with obesity, defined by a high BMI and the presence of associated diseases.

3. ** Type III (extreme) obesity:**.

• **BMI:** more than 40.0 kg/m² (class III).
• **Diagnosis:** Extreme health risk, requiring urgent treatment and management.

Classification of obesity by fat distribution:

1. **Apple-type obesity:**.

• **Characteristics:** More fat in the abdominal area, leading to an “apple shape.”
• **Recognition:** Men with waist circumference greater than 102 cm, women with waist circumference greater than 88 cm.

2. **Pear type obesity:**.

• **Characteristics:** More fat in the hips and thighs, leading to a “pear shape.”
• **Diagnosis:** Men and women with large hip circumference and a waist-to-hip ratio of less than 0.85 (in women) or 0.90 (in men).

Classification of obesity by body fat distribution:

1. ** Gynoid obesity:**.

• **Characteristics:** Excessive fat localized around the hips and thighs.
• **Recognition:** Visible increase in the circumference of the hips and buttocks.

2. **Android obesity:**.

• **Characteristics:** Excess fat located in the abdominal and chest area.
• **Recognition:** Visible increase in waist circumference.

The classification of obesity in women and men may be similar, but differences in fat distribution and other factors can lead to subtle differences in diagnosis and treatment approaches. It is worth emphasizing that the diagnosis and treatment of obesity should always be carried out by medical professionals.

3. Selection of peptides according to the situation in points 1 and 2

Assuming you have all the tests normal, below are the diagrams used by other people. Before starting therapy, take body measurements in chest, abdomen, hips, thighs and take a starting weight measurement

• Gynoid obesity (described above):

1-4 week TIRZ 5 mg once a week

Every week fasting on the same day weight control, after 4 weeks girth verification, if the decrease is noticeable 5-10 week TIRZ 5 mg once a week, if there are no results, the next step:

5-10 week TIRZ 10 mg once a week

Every week fasting on the same day weight control, after 4 weeks girth verification, if the decrease is noticeable 10-15 week TIRZ 10 mg once a week.

• Android obesity (described above):

1-4 week TIRZ 5 mg once a week (e.g., Saturday).

1-4 week RETA 5 mg once a week (e.g., Wednesday).

Every week fasting on the same day weight control, after 4 weeks girth verification, if the decrease is noticeable 5-10 week TIRZ 5 mg and RETA 5 mg once a week, if there are no results, the next step:

5-10 week TIRZ 10 mg once a week (e.g., Saturday).

5-10 week RETA 5 mg once a week (e.g., Wednesday).

Every week fasting on the same day weight control, after 4 weeks girth verification, if the decrease is noticeable 10-15 week TIRZ 10 mg once a week.

This is not medical advice, you should consult your doctor for any regimen of use !